Cellagen Technology is a biotechnology startup focused on advancing scientific research through the development of specialty reagents and instruments based on cutting-edge technologies in medicinal chemistry and stem cell biology. Founded in 2011, the company offers a product portfolio that spans chemical compounds related to signaling pathways, cellular mechanisms, and disease research, as well as a broad range of kits, growth factors, and stem cell-related reagents.
■ Product Portfolio
Vicbio Biotechnology Co., Ltd. provides the full range of Cellagen Technology products.
⇨ Inquire or Order immediately ⇦
●Chemical Compound Reagents
A variety of chemical reagent combinations designed for specific experimental reactions and research applications, supporting complex laboratory needs.
●Molecular Targets
Products that help researchers identify and study specific molecular targets, including Ser/Thr kinases, tyrosine kinases, phosphatases, nuclear receptors, ion channels, proteases, and GPCR-related targets, playing an important role in molecular biology research.
●Signaling Pathways
Research tools and related products for the study of intracellular signaling pathways, including Hedgehog, Notch, Wnt, GPCR-related pathways, PI3K/Akt/mTOR, and BMP/TGF-β pathways, helping researchers better understand the regulatory mechanisms of cellular activities.
●Cellular Mechanisms
Products for investigating intracellular functional mechanisms, including research reagents for angiogenesis, apoptosis, autophagy, metabolism, ubiquitination/proteasome biology, cell cycle regulation, DNA damage and repair, and epigenetics.
●Disease Areas
Products focused on research in specific disease fields, including neuroscience, pulmonary diseases, kidney diseases, infectious diseases, musculoskeletal disorders, oncology, immunology, ophthalmology, cardiovascular diseases, and metabolic disorders, supporting studies on disease mechanisms, diagnosis, and treatment.
●Stem Cell-Related Products
Drawing on the company’s strengths in stem cell research, Cellagen Technology provides a range of products for stem cell studies, including tools and reagents for stem cell culture and differentiation.
●Growth Factors
As an important class of bioactive substances, the company’s growth factor products are used in research areas such as cell culture and tissue repair. This product line also includes a variety of inhibitors, such as Wnt inhibitors, HDAC inhibitors, ROCK inhibitors, and PDK1 inhibitors.
■ Product List
| Product name | Cat. # | Size |
| FlexiWash FW400 | FW400 | - |
| 2 × Phanta UniFi Master Mix P516 | P516-1 | 1 ml; 5 × 1 ml; 15 × 1 ml |
| VAHTS Library Quantification Kit for Illumina NQ101-NQ104 | NQ101-NQ104 | 500 rxns |
| Equalbit 1x dsDNA HS Assay Kit EQ121 | EQ121 | 100 rxns; 500 rxns |
| VAHTS RNA Clean Beads N412 | N412 | 5ml; 40ml; 450ml |
| Ribo-off rRNA Depletion Kit (Plant) N409 | N409 | 12 rxns; 24 rxns |
| VAHTS Multiplex Oligos Set 4/5 for Illumina N321-N322 | N321-N322 | 192 rxns |
| Ribo-off Globin & rRNA Depletion Kit (Human/Mouse/Rat) N408 | N408 | 24 rxns; 96 rxns |
| miRNA 1st Strand cDNA Synthesis Kit (by stem-loop) MR101 | MR101 | 50 rxns (20 µl/rxn); 100 rxns (20 µl/rxn) |
| VAHTS Serum/Plasma Circulating DNA Kit N902 | N902 | 200 rxns |
| Magnetic Separation Rack CM103 | CM103 | 24 well (1.5ml/ well) |
| Automated Liquid Handling Workstation VNL-96P | VNL-96P | - |
| FastPure Bacteria DNA DC103 | DC103 | 100 rxns |
| dUTP (100 mM) P033 | P033 | 1 ml |
| LAMP Fluorescent Dye RP001 | RP001 | 100 μl |
| dCTP (100 mM) P036 | P036 | 1 ml |
| dGTP (100 mM) P037 | P037 | 1 ml |
| dTTP (100 mM) P035 | P035 | 1 ml |
| dATP (100 mM) P034 | P034 | 1 ml |
| Magnetic Separation Rack CM101 | CM101 | 32 hole,200 ul |
| ChamQ SYBR qPCR Master Mix (High ROX Premixed) Q341 | Q341 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| DL2000 Plus DNA Marker MD101 | MD101 | 50 rxns (5 µl/rxn); 100 rxns (5 µl/rxn) |
| AccurSTART One Step RT-qPCR Probe Kit (Glycerol-free) QL227-EN | QL227-EN | 200 rxns; 1000 rxns; 5000 rxns |
| FastPure Plant DNA Isolation Mini Kit DC104 | DC104 | 50 rxns |
| Taq HS DNA Polymerase (Glycerol-free) QL101 | QL101 | 1000 U; 5000 U; 50000 U |
| Ultra-Universal TOPO Cloning Kit C603 | C603 | 20 rxns; 40 rxns |
| EasyAna dsRNA (Modified) Quantitative Detection Kit (ELISA) 2.0 DD3509EN | DD3509EN | 96 tests |
| Spike Antibody (IgG) Quantitative and Qualitative Detection Kit (ELISA) DD3114PEN | DD3114PEN | 96 tests |
| RBD Antibody (IgG) Quantitative and Qualitative Detection Kit (ELISA) DD3112PEN | DD3112PEN | 96 tests |
| ChamQ SYBR qPCR Master Mix (Without ROX) Q321 | Q321 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| ChamQ SYBR qPCR Master Mix Q311 | Q311 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| T7 High Yield RNA Transcription Kit (N1-Me-Pseudo UTP) DD4202EN | DD4202EN | 50 rxns |
| T7 High Yield RNA Transcription Kit DD4201EN | DD4201EN | 50 rxns |
| AccurSTART One Step RT-qPCR Probe Kit (FOR FAST) Q231-EN | Q231-EN | 200 rxns; 1000 rxns; 10000 rxns |
| VAHTS ssDNA Library Prep Kit for Illumina ND620 | ND620 | 24 rxns; 96 rxns |
| ChamQ SYBR qPCR Master Mix (Low ROX Premixed) Q331 | Q331 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| ChamQ SYBR Color qPCR Master Mix (Without ROX) Q421 | Q421 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| ChamQ SYBR Color qPCR Master Mix Q411 | Q411 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| VAHTS Dual UMI UDI Adapters Set 1 – Set 4 for lllumina N351-N354 | N351-N354 | 96 rxns |
| Taq Pro Multiplex DNA Polymerase PM201 | PM201 | 200 rxns; 1,000 rxns |
| AccurSTART One Step RT-qPCR Super PreMix (ONE TUBE) Q621-EN | Q621-EN | 200 rxns (20 μl/rxn); 1000 rxns (20 μl/rxn); 10000 rxns (20 μl/rxn) |
| VAHTS AmpSeq Multi-PCR Module V3 NA215 | NA215 | 24 rxns; 96 rxns |
| VAHTS Universal Plus DNA Library Prep Kit for Illumina V2 ND627 | ND627 | 24 rxns; 96 rxns |
| Animal ASFV Detection Probe Super Premix QV114-EN | QV114-EN | 400 rxns; 800 rxns |
| VAHTS AmpSeq Library Prep Kit V3 NA210 | NA210 | 24 rxns; 96 rxns |
| ChamQ SYBR Color qPCR Master Mix (High ROX Premixed) Q441 | Q441 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| ChamQ SYBR Color qPCR Master Mix (Low ROX Premixed) Q431 | Q431 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| Taq Pro Multiplex DNA Polymerase (High specificity) PM202 | PM202 | 200 rxn; 1000 rxn |
| Taq Pro Multiple Probe qPCR Mix QN213-EN | QN213-EN | 100 rxns; 500 rxns; 2500 rxns |
| Taq HS DNA Polymerase P132 | P132 | 500 U (5 μl/rxn); 1000 U (5 μl/rxn); 5000 U (5 μl/rxn) |
| HiScript II Reverse Transcriptase R201 | R201 | 2000 U; 10000 U |
| HiScript III All-in-one RT SuperMix Perfect for qPCR R333 | R333 | 100 rxns (20 μl/rxn) |
| HiScript II One Step qRT-PCR SYBR Green Kit Q221 | Q221 | 250 rxns (20 μl/rxn) |
| HiScript III One Step qRT-PCR Probe Kit Q225-EN | Q225-EN | 100 rxns; 1000 rxns; 5000 rxns |
| HiScript III One Step qRT-PCR Probe 5 × Master Mix Q611-EN | Q611-EN | 100 rxns; 1000 rxns; 10000 rxns |
| FastPure Gel DNA Extraction Mini Kit DC301 | DC301 | 100 rxns |
| VAHTS Universal V8 RNA-seq Library Prep Kit for Illumina NR605 | NR605 | 24 rxns; 96 rxns |
| VAHTS HiFi Universal Amplification Mix for Illumina N618 | N618 | 24 rxns; 96 rxns |
| Taq Pro Universal SYBR qPCR Master Mix Q712 | Q712 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| 2 × Taq Plus Master Mix (Dye Plus) P212 | P212 | 5 × 1 ml; 15 ml; 50 ml |
| 2 × Phanta Flash Master Mix (Dye Plus) P520 | P520 | 1 ml; 5 × 1 ml; 15 × 1 ml |
| 2 × Phanta Flash Master Mix P510 | P510 | 1 ml; 5 × 1 ml; 15 × 1 ml |
| T7 RNAi Transcription Kit TR102 | TR102 | 25 rxns; 50 rxns |
| T7 High Yield RNA Transcription Kit TR101 | TR101 | 50 rxns; 100 rxns |
| Myco-Off Mycoplasma Cleaner D103 | D103 | 100 μl; 500 μl; 1000 μl |
| BCA Protein Quantification Kit E112 | E112 | 250 rxns; 500 rxns |
| MycoBlue Mycoplasma Detector D101 | D101 | 20 rxns; 50 rxns |
| Dual Luciferase Reporter Assay Kit DL101 | DL101 | 100 rxns (100 μl/rxn) |
| CCK-8 Cell Counting Kit A311 | A311 | 500 rxns (10 μl/rxn); 1,000 rxns (10 μl/rxn) |
| Annexin V-FITC/PI Apoptosis Detection Kit A211 | A211 | 50 rxns; 100 rxns |
| VAHTS RNA Multiplex Oligos set 1 for Illumina N323-N324 | N323-N324 | 192 rxns |
| VAHTS RNA Adapters set8 for MGI NM208 | NM208 | 10 μl; 40 μl |
| FastPure Cell/Tissue Total RNA Isolation Kit V2 RC112 | RC112 | 50 rxns |
| FastPure EndoFree Plasmid Maxi Kit DC202 | DC202 | 10 rxns |
| HiScript II One Step qRT-PCR Probe Kit Q223-EN | Q223-EN | 250 rxns (20 μl/rxn) |
| ChamQ Geno-SNP Probe Master Mix Q811 | Q811 | 500 rxns (20 μl/rxn); 2500 rxns (20 μl/rxn) |
| AceQ Universal Probe Master Mix V2 Q513-EN | Q513-EN | 500 rxns (20 μl/rxn); 2500 rxns (20 μl/rxn) |
| ChamQ Universal SYBR qPCR Master Mix Q711 | Q711 | 500 rxns (20 μl/rxn); 2,500 rxns (20 μl/rxn) |
| DNase I , RNase-free EN401-402 | EN401-402 | 1000U; 10000U; 1000U; 10000U |
| M-MLV (H-) Reverse Transcriptase R021 | R021 | 10,000 U |
| HiScript III 1st Strand cDNA Synthesis Kit (+gDNA wiper) R312 | R312 | 50 rxns (20 µl/rxn); 100 rxns (20 µl/rxn) |
| DL15000 DNA Marker MD103 | MD103 | 50 rxns (5 µl/rxn); 100 rxns (5 µl/rxn) |
| DL5000 DNA Marker MD102 | MD102 | 50 rxns (5 µl/rxn); 100 rxns (5 µl/rxn) |
| Ultra GelRed (10,000 ×) GR501 | GR501 | 0.5 ml; 10 × 0.5 ml; 100 × 0.5 ml |
| 5 min TA/Blunt-Zero Cloning Kit C601 | C601 | 25 rxns (5 µl/rxn); 50 rxns (5 µl/rxn) |
| 5min Universal Ligation Mix C311 | C311 | 50 rxns (10µl/rxn); 100 rxns (10µl/rxn) |
| T4 DNA Ligase C301 | C301 | 40000 U |
| ClonExpress Ultra One Step Cloning Kit C115 | C115 | 25 rxns; 50 rxns |
| HiScript III RT SuperMix for qPCR (+gDNA wiper) R323 | R323 | 100 rxns (20 μl/rxn) |
| 100 bp DNA Ladder MD104 | MD104 | 50 rxns (5 µl/rxn); 100 rxns (5 µl/rxn) |
| HiScript III Reverse Transcriptase R302 | R302 | 10,000 U |
| 2 × Rapid Taq Master Mix P222 | P222 | 5 ml; 15 ml; 50 × 1 ml; 10 × 5 ml |
| Plant Direct PCR Kit PD105 | PD105 | 200 rxns (50µl/rxn) |
| 2 × Vazyme LAmp Master Mix (Dye Plus) P312 | P312 | 5 × 1 ml; 15 × 1 ml |
| One Step Mouse Genotyping Kit PD101 | PD101 | 200 rxns (50µl/rxn) |
| 2 × Taq Plus Master Mix Ⅱ (Dye Plus) P213 | P213 | 5 × 1 ml; 15 × 1 ml; 50 × 1 ml |
| 2 × Taq Master Mix (Dye Plus) P112 | P112 | 5 × 1 ml; 15 × 1 ml; 50 × 1 ml |
| 2 × Taq Plus Master Mix P211 | P211 | 5 × 1 ml; 15 × 1 ml; 50 × 1 ml |
| 2 × Phanta Max Master Mix (Dye Plus) P525 | P525 | 1 ml; 5 × 1 ml; 15 × 1 ml |
| 2 × Phanta Max Master Mix P515 | P515 | 1 ml; 5 × 1 ml; 15 × 1 ml |
| Equalbit RNA HS Assay Kit EQ211 | EQ211 | 100 rxns; 500 rxns |
| Phanta Max Super-Fidelity DNA Polymerase P505 | P505 | 100 U; 500 U; 1000 U |
| VAHTS Library Quantification Kit for IIIumina DNA Standard 1-6 NQ105 | NQ105 | 6x96 μl |
| Library Dilution Buffer NQ106 | NQ106 | 50ml |
| dNTP Mix (10 mM each) P031 | P031 | 1 ml; 5 × 1 ml |
| Discover-sc Single Cell WGA Kit N603 | N603 | 24 rxns; 96 rxns |
| Ribo-off rRNA Depletion Kit (Human/Mouse/Rat) N406 | N406 | 24 rxns; 96 rxns |
| VAHTS RNA Adapters Set 3 – Set 6 for Illumina N809-N812 | N809-N812 | 192 rxns |
| T4 DNA Ligase (Rapid) N103 | N103 | 600000 U |
| VAHTS Circularization Kit for MGI NM201 | NM201 | 16 rxns; 48 rxns |
| VAHTS DNA Adapters Set 8 for MGI NM108 | NM108 | 10 μl; 40 μl |
| VAHTS DNA Clean Beads N411 | N411 | 5 ml; 60 ml; 450 ml |
| VAHTS DNA Adapters Set 3 – Set 6 for Illumina N805-N808 | N805-N808 | 20 μl |
| RNase, RNA and DNA Remover R504 | R504 | 250 mL |
| FastPure Plant Total RNA Isolation Kit (Polysaccharides / Polyphenolics-Rich) RC401 | RC401 | 50 rxns |
| Mut Express II Fast Mutagenesis Kit V2 C214 | C214 | 10 rxns; 25 rxns |
| Mut Express MultiS Fast Mutagenesis Kit V2 C215 | C215 | 10 rxns; 25 rxns |
| RoomTemp Sample Lysis Kit P073 | P073 | 250 rxns; 1000 rxns |
| Bst II DNA Polymerase Large Fragment P702 | P702 | - |
| Bst II Pro DNA Polymerase Large Fragment P703 | P703 | - |
| VAHTS PCR-Free DNA Adapters for MGI NM10902 | NM10902 | 20 μl |
| VAHTS PCR-Free DNA Adapters for MGI NM10903 | NM10903 | 20 μl |
| VAHTS Small RNA Index Primer Kit for Illumina N813-N816 | N813-N816 | 48 rxns |
| Automatic Nucleic Acids Extraction Instrument VNP-32P | VNP-32P | 1 |
| Full-automatic nucleic acids extraction instrument VNP-96 | VNP-96 | 1 |
| MiPure Cell/Tissue miRNA Kit (Spin Column) RC201-EN | RC201-EN | 50 rxns |
| 230 μl Robotic Pipette Tips RTB02301-EN | RTB02301-EN | 50 Boxes/Case |
| 0.2 ml Skirted Micro Well Plates RSP09602-EN | RSP09602-EN | 50 Plates/Box |
| 15 mI Centrifuge Tubes TCF00115 | TCF00115 | 500/Case |
| 50 mI Centrifuge Tubes TCF00150 | TCF00150 | 500/Case |
| 0.1 ml 8-Tube PCR Strips (with Caps) PCR00801-EN | PCR00801-EN | 125 Strips; 10 Boxes/Case |
| Pressure-Activated Plate Sealing Films PCR09600PF | PCR09600PF | 100/Box |
| Self-Adhesive Plate Sealing Films PCR09600SF | PCR09600SF | 100/Box |
| FastPure Host Removal and Microbiome DNA Isolation Kit DC501-01 | DC501-01 | 50 rxns |
| FastPure Microbiome DNA Isolation Kit DC502-01 | DC502-01 | 50 rxns |
| 200 μl Pipette Tips (Rack) PTR02011 | PTR02011 | 960 (10 racks of 96) / Unit; 4800 (5 units of 960) / Case |
| 1000 μl Pipette Tips (Rack) PTR10011 | PTR10011 | 960 (10 racks of 96) / Unit; 4800 (5 units of 960) / Case |
| 10 μl Pipette Tips (Filtered, Rack) PTR00121 | PTR00121 | 960 (10 racks of 96) / Unit; 4800 (5 units of 960) / Case |
| 200 μl Pipette Tips (Filtered, Rack) PTR02021 | PTR02021 | 960 (10 racks of 96) / Unit; 4800 (5 units of 960) / Case |
| 1000 μl Pipette Tips (Filtered, Rack) PTR10021 | PTR10021 | 960 (10 racks of 96) / Unit; 4800 (5 units of 960) / Case |
| 25 ml Disposable Serological Pipette CPP00025 | CPP00025 | 200/Case (25/Pack, 8 Packs/Case) |
| 10 ml Disposable Serological Pipette CPP00010 | CPP00010 | 200/Case (50/Pack, 4 Packs/Case) |
| 50 ml Disposable Serological Pipette CPP00050 | CPP00050 | 100/Case (25/Pack, 4 Packs/Case) |
| 25 cm2 Cell Culture Flask CCF00025 | CCF00025 | 200/Case (10/Pack, 20 Packs/Case) |
| 75 cm2 Cell Culture Flask CCF00075 | CCF00075 | 100/Case (5/Pack, 20 Packs/Case) |
| Cell Culture Plate, 6 Well CCP01006 | CCP01006 | 50/Case (1/Pack, 50 Packs/Case) |
| Cell Culture Plate, 96 Well CCP01096 | CCP01096 | 100/Case (1/Pack, 100 Packs/Case) |
| 5 ml Disposable Serological Pipette CPP00005 | CPP00005 | 200/Case (50/Pack, 4 Packs/Case) |
| 0.2 ml 8-Tube PCR Strips (with Caps) PCR00802-EN | PCR00802-EN | 125 Strips; 10 Boxes/Case |
| 10 μl Pipette Tips (Rack) PTR00111 | PTR00111 | 960 (10 racks of 96) / Unit; 4800 (5 units of 960) / Case |
| Animal ASFV Detection Probe Master Mix QV110-EN | QV110-EN | 400 rxns; 800 rxns |
| Ribo-off rRNA Depletion Kit V2 (Bacteria) N417 | N417 | 12 rxns; 24 rxns |
| Ribo-MagOff rRNA Depletion Kit (Human/Mouse/Rat) N420 | N420 | 12 rxns; 24 rxns |
| VAHTS Maxi Unique Dual Index DNA Adapters Set 1 – Set 4 for Illumina N34201-N34204 | N34201-N34204 | 384 rxns |
| VAHTS Target Capture Core Exome Panel NC001 | NC001 | 24 rxns; 96 rxns |
| VAHTS Target Capture Universal Blockers and Post-PCR Primer Mix for Illumina-TS NC101 | NC101 | 24 rxns; 96 rxns |
| VAHTS Target Capture Hybridization and Wash Kit NC103 | NC103 | 24 rxns; 96 rxns |
| VAHTS Target Capture Universal Blockers and Post-PCR Primer Mix for MGI-SI NCM101 | NCM101 | 24 rxns; 96 rxns |
| VAHTS HiFi Universal Amplification Mix for MGI (SI) NM618 | NM618 | 24 rxns; 96 rxns |
| ClonExpress II One Step Cloning Kit C112 | C112 | 25 rxns (20 µl/rxn); 50 rxns (20 µl/rxn) |
| ClonExpress MultiS One Step Cloning Kit C113 | C113 | 10 rxns; 25 rxns |
| VAHTS PCR-Free DNA Adapters for MGI NM10904 | NM10904 | 20 μl |
| FastPure Plasmid Mini Kit DC201 | DC201 | 100 rxns |
| ClonExpress Ultra One Step Cloning Kit V2 C116 | C116 | 20 rxn; 40 rxn |
| miRNA 1st Strand cDNA Synthesis Kit (by tailing A) MR201 | MR201 | 20 rxns (20 µl/rxn) ; 50 rxns (20 µl/rxn) |
| VAHTS Dual UMI UDB Adapters Set 1-8 for MGI NM35101-NM35108 | NM35101-NM35108 | 20 μl |
| EpiArt DNA Methylation Library Kit for Illumina V3 NE103 | NE103 | 24 rxns; 96 rxns |
| HiScript IV RT SuperMix for qPCR (+gDNA wiper) R423 | R423 | 100 rxns (20 µl/rxn) |
| FastPure Cell/Tissue DNA Isolation Mini Kit DC102 | DC102 | 100 rxns |
| FastPure EndoFree Plasmid Mini Kit DC203 | DC203 | 50 rxns |
| FastPure FFPE DNA Isolation Kit DC105 | DC105 | 50 rxns |
| VAMNE Virus DNA/RNA Extraction Kit 3.0 (96 Prepackaged) RM502 | RM502 | 96 T |
| VAMNE Magnetic Pathogen DNA/RNA Kit RM601 | RM601 | 50 rxns |
| VAHTS mRNA Capture Beads 2.0 N403 | N403 | 24 rxns; 96 rxns |
| VeZol Reagent R411 | R411 | 100ml; 200ml |
| SuperFemto ECL Chemiluminescence Kit E423 | E423 | 100 ml; 500 ml |
| Murine RNase Inhibitor R301 | R301 | 2,000 U; 10,000 U; 20,000 U |
| FastPure Viral DNA/RNA Mini Kit Pro RC323 | RC323 | 50 rxns |
| EpiArt DNA Enzymatic Methylation Kit EM301 | EM301 | 24 rxns; 96 rxns |
| VAHTS Small RNA Library Prep Kit for Illumina V2 NR811 | NR811 | 24 rxns; 96 rxns |
| FastPure Blood/Cell/Tissue/Bacteria DNA Isolation Mini Kit DC112 | DC112 | 50 rxns; 200 rxns |
| FreeZol Reagent R711 | R711 | 200 rxns; 400 rxns |
| VAMNE Virus DNA/RNA Extraction Kit 3.0 (32 Prepackaged) RM501 | RM501 | 50T; 48T; 96T |
| EpiArt Magnetic DNA Methylation Bisulfite Kit EM103 | EM103 | 50rxns; 200rxns |
| SuperPico ECL Chemiluminescence Kit E422 | E422 | 100 ml; 500 ml |
| 250 kDa Plus Prestained Protein Marker MP202 | MP202 | 100 rxns; 500 rxns |
| 180 kDa Plus Prestained Protein Marker MP201 | MP201 | 100 rxns; 500 rxns |
| Lipomaster 2000 Transfection Reagent TL201 | TL201 | 1.5 ml; 4 × 1.5 ml |
| HiScript II Reverse Transcriptase (Glycerol-free) RL201 | RL201 | 10,000 U; 40,000 U |
| AccurSTART Reverse Transcriptase RW201 | RW201 | 10,000 U; 40,000 U |
| AccurSTART Reverse Transcriptase (Glycerol-free) RWL201 | RWL201 | 10,000 U; 40,000 U |
| Murine RNase Inhibitor (Glycerol-free) RL301 | RL301 | 2,000 U; 10,000 U; 20,000 U |
| RTv Reverse Transcriptase RV101 | RV101 | 1,500 U |
| RTv Reverse Transcriptase (Glycerol-free) RVL101 | RVL101 | 1,500 U |
| Virus DNA/RNA Extraction Kit 2.0 (Prepackaged) RM401 | RM401 | 50×1T; 6×8T; 6×16T |
| Anti-rabbit IgG for IP (HRP) RA1008 | RA1008 | 100 μl |
| Hyperactive pG-MNase for CUT&RUN S702 | S702 | 200 rxns |
| 2 × Taq Master Mix P111 | P111 | 5 × 1 ml; 15 × 1 ml; 50 × 1 ml |
| Magnetic Blood DNA Extraction Kit (Prepackaged) DM102 | DM102 | 2×16T; 6×16T |
| TUNEL BrightGreen Apoptosis Detection Kit A112 | A112 | 20 rxns; 50 rxns; 100 rxns |
| Equalbit RNA BR Assay Kit EQ212 | EQ212 | 100 assays; 500 assays |
| VAMNE MagUltra Blood Genomic DNA Extraction Kit DM101 | DM101 | 50 rxns; 200 rxns |
| VAMNE Magnetic Pathogen DNA/RNA Kit (Prepackaged) RM602 | RM602 | 64T (6 × 16 T) |
| Discover-sc WTA Kit V2 N711 | N711 | 12 rxns; 24 rxns; 96 rxns |
| 2 × Vazyme LAmp Master Mix P311 | P311 | 5 × 1 ml; 15 × 1 ml |
| FastSelect rRNA Kit (Human) N460 | N460 | 24 rxns; 96 rxns |
| VAHTS CA-28 Streptavidin Beads N512 | N512 | 2.5ml; 10ml |
| VAHTS Universal V10 RNA-seq Library Prep Kit for Illumina NR606 | NR606 | 24 rxns; 96 rxns |
| FastPure Universal Plant Total RNA Isolation Kit RC411 | RC411 | 50 rxns |
| Reprime-5C (3000x) | Primary hepatocyte culture cocktail | K5266 | 0.5 ml |
| Repro-PACT | K7228-500 | 0.5mL of 1000x,0.2mL of 5000x,1.0mL of 5000x |
| Repro-ThiPSC | Enhance reprogramming efficiency cocktail | K8447-500 | 0.5mL of 1000x |
| Repro-nSC (1000x) | K6720-500 | 0.5mL of 1000x |
| Repro-nLS3i (1000x) | K6572-500 | 0.5mL of 1000x |
| Repro-n3i (1000x) | Neuron differentiation cocktail | K6571-500 | 0.5mL of 1000x |
| Repro-nLS (1000x) | neural/neuronal cell generation cocktail | K6570-500 | 0.5mL of 1000x |
| Repro-nLSC (1000x) | neural/neuronal cell generation cocktail | K5722-500 | 0.5mL of 1000x |
| Repro-ACTH2i (1000x) | K2284 | 0.25mL of 1000x |
| Foretinib (GSK1363089) | C4136-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Axitinib (AG 013736) | C2413-10 | 10 mg; 50 mg; 250 mg |
| LY-2228820 | C5922-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BGJ398 (NVP-BGJ398) | C6245-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| VX-770 (Ivacaftor) | CFTR potentiator | C8770-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BAY-73-4506 (Regorafenib) | Tyrosine kinase inhibitor | C2734-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Zearalenone (Toxin F2) | ER agonist | C9327-10 | 10 mg; 50 mg; 250 mg |
| BI-1356 (Linagliptin) | DPP-IV/DPP-4 inhibitor | C2135-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AG-1024 | IGF-1R inhibitor | C2102-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| VX-765 | Caspase 1/Interleukin-converting enzyme inhibitor | C8976-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PQ401 | IGF-1R inhibitor | C7740-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PNU-282987 | nAChR agonist | C7282-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Latanoprost | Prostaglandin F receptor (FP) agonist | C5282-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GW501516 | PPARδ agonist | C4950-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GW4064 | non-steroidal FXR agonist | C4940-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK1292263 | GPR119 agonist | C4129-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BX-912 | PDK1 inhibitor | C2991-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIBR-1048 (Dabigatran etexilate) | Thrombin inhibitor | C2104-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AT7519 | CDK inhibitor | C2875-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AP26113 | ALK inhibitor | C2726-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Ambrisentan | Endothelin receptor type A/ETa antagonist | C2627-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AS-703026 (Pimasertib) | MEK1/2 inhibitor | C2770-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIRB796 (Doramapimod) | P38 MAPK inhibitor | C2796-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-AUY954 | S1P1 agonist | C6295-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GNF-2 | Allosteric Abl inhibitor | C4632-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SYN115 | Adenosine A(2a) receptor antagonist | C7911-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SU5416 (Semaxinib) | Flk-1/KDR inhibitor | C7541-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Prucalopride | 5-HT4 receptor agonist | C7782-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MK-0524 (Laropiprant) | Prostaglandin D2/DP antagonist | C6052-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ABT-378 (Lopinavir) | HIV-1 protease inhibitor | C2378-10 | 10 mg; 50 mg; 250 mg |
| TMC114 (Darunavir) | HIV-1 protease inhibitor | C8114-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CP-724714 | HER2 inhibitor | C2772-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Alcaftadine | Histamine (H1/H4) receptor antagonist | C2522-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Necrosulfonamide (NSA) | Necrosis inhibitor | C6327-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Y-27632 | ROCK inhibitor | C9127-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| VX-680 (Tozasertib) | Aurora A inhibitor | C8916-10 | 10 mg; 50 mg; 250 mg |
| Thiazovivin | ROCK inhibitor | C8442-1s | 1 mg;5 mg; 25 mg |
| SU5402 | FGFR/VEGFR/PDGFR inhibitor | C7854-1s | 1 mg;5 mg; 25 mg |
| Staurosporine | pan-kinase inhibitor | C7828-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| PS48 | PDK1 inhibitor | C7748-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RO4929097 | γ-secretase inhibitor | C7649-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Sitagliptin | DPP-IV/DPP-4 inhibitor | C7482-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| R406 | SYK inhibitor | C7406-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CP-358774 (Erlotinib, OSI-774) | EGFR inhibitor | C2735-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIBF1120 (Vargatef, Nintedanib) | VEGFR/PDGFR/FGFR inhibitor | C2311-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ZD6474 (Vandetanib) | KDR/VEGFR2 inhibitor | C9364-10 | 10 mg; 50 mg; 250 mg |
| ZD1839 (Gefitinib, Iressa) | EGFR inhibitor | C9318-10 | 10 mg; 50 mg; 250 mg |
| YO-01027 (Dibenzazepine) | gamma-secretase inhibitor | C9601-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| VX-950 (Telaprevir) | HCV protease inhibitor | C8995-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| VX-702 | P38 MAPK inhibitor | C8970-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| VX-478 (Amprenavir) | HIV-1 protease inhibitor | C8947-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TG101348 (SAR302503) | JAK2 inhibitor | C8134-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TG101209 | JAK2/3 inhibitor | C8120-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TAK-875 | GPR40 agonist | C8875-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| SU6668 (Orantinib) | KDR/FGFR/PDGFR inhibitor | C7866-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SU11274 | cMET inhibitor | C7811-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| STI571 (Imatinib, Gleevec) | Abl/cKit/PDGFR inhibitor | C6784-10 | 10 mg; 50 mg; 250 mg |
| SPM-927 (Lacosamide) | C7927-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SP600125 | JNK2/JNK3 inhibitor | C7760-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Sorafenib | Raf1 inhibitor | C7672-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Skepinone-L | p38 MAPK inhibitor | C7537-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| SGX523 | cMET inhibitor | C7523-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SD-169 | p38 MAPK inhibitor | C7216-10 | 10 mg; 50 mg; 250 mg |
| SB203580 | p38 MAPK inhibitor | C7320-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RU58841 | nonsteroidal anti-androgen | C7858-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RO318959 (Saquinavir) | HIV-1 protease inhibitor | C7318-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Rivaroxaban (Xarelto) | Protease Factor Xa inhibitor | C7472-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| R788 (Fostamatinib disodium) | Orally active Syk inhibitor | C7788-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PS-341 (Bortezomib) | Proteasome inhibitor | C7734-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PP242 | mTOR inhibitor | C7724-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PLX-4720 | B-RAF inhibitor | C7420-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PLX-4032 (Vemurafenib) | B-Raf inhibitor | C7403-10 | 10 mg; 50 mg; 250 mg |
| PHA-793887 | CDK2/5/7 inhibitor | C7793-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PHA-665752 | cMET/RON inhibitor | C7665-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-562271 | FAK/Pyk2 inhibitor | C7562-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-299804 (Dacomitinib) | HER1/2/3 inhibitor | C7299-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-2341066 (Crizotinib) | cMet/ALK inhibitor | C7234-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-04217903 | cMet inhibitor | C7042-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Perifosine | Akt/PI3K inhibitor | C7374-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PD98059 | MEK inhibitor | C7980-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PD153035 | EGFR inhibitor | C7153-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PCI-32765 (Ibrutinib) | BTK inhibitor | C7327-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| OSI-906 (Linsitinib) | IFG-1R/IR inhibitor | C6906-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-TAE684 | ALK inhibitor | C6823-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MK-2206 | Akt1/Akt2/Akt3 inhibitor | C6220-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MG132 | Proteasome inhibitor | C6413-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MDV3100 (Enzalutamide) | AR antagonist | C6310-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2886721 | BACE inhibitor | C5288-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2811376 | BACE inhibitor | C5281-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2784544 | JAK2 inhibitor | C5178-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2109761 | TGF-β receptor type I/II inhibitor | C5210-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| LX7101 | LIMK2 inhibitor | C5971-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| KU-55933 | ATM kinase inhibitor | C5855-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| INNO-406 (Bafetinib) | Abl/Lyn inhibitor | C4406-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| HKI-272 (Neratinib) | HER2/EGFR inhibitor | C4272-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GW572016 (Lapatinib) | ErbB-2/EGFR inhibitor | C4920-10 | 10 mg; 50 mg; 250 mg |
| GSK1838705A | IGF-1R/IR/ALK inhibitor | C4183-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK1120212 (Trametinib) | MEK1/2 inhibitor | C4112-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GDC-0879 | B-Raf inhibitor | C4087-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CX-4945 (Silmitasertib) | CK2a kinase inhibitor | C2949-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CP-868596 (Crenolanib) | PDGFR inhibitor | C2786-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CGS-21680 | A2A receptor agonist | C2216-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BX795 | PDK1/TBK1 inhibitor | C2979-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-777607 | Met/Axl/Ron inhibitor | C2777-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-599626 | Her1/Her2 inhibitor | C2599-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-477118 (Saxagliptin) | DPP-IV inhibitor | C2477-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-354825 (Dasatinib) | Abl/Src inhibitor | C2354-10 | 10 mg; 50 mg; 250 mg |
| BMS-232632 (Atazanavir) | HIV-1 protease inhibitor | C2232-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIBW2992 (Afatinib) | EGFR, Her2 inhibitor | C2929-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BAPTA-AM | Ca2+ chelator | C2278-10 | 10 mg; 50 mg; 250 mg |
| AZD6244 (Selumetinib) | MEK1 inhibitor | C2624-10 | 10 mg; 50 mg; 250 mg |
| AZD5438 | CDK 1/2/9 inhibitor | C2543-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD4547 | FGFR1/2/3 inhibitor | C2454-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZ-628 | Raf inhibitor | C2962-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AV-951 (Tivozanib) | VEGFR1/2/3, cKit, PDGFR inhibitor | C2895-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AP24534 (Ponatinib) | Abl, Src, FGFR, VEGFR inhibitor | C2724-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AMG-706 (Motesanib) | Pan-VEGFR inhibitor | C2706-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AICAR | AMPK activator | C2422-10 | 10 mg; 50 mg; 250 mg |
| AC220 (Quizartinib) | FLT3 inhibitor | C2222-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| ABT-869 (Linifanib) | KDR, CSF-1R, FLT1/3, PDGFRb inhibitor | C2869-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SF1670 | PTEN inhibitor | C7316-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GDC-0068 | Pan-Akt inhibitor | C4006-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| XL184 (Cabozanitinib) | VEGFR2/MET inhibitor | C9518-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PD0325901 | MEK1/2 inhibitor | C7303-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| INCB018424 | JAK1/2 inhibitor | C4622-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| BMS-708163 (Avagacestat) | γ-secretase inhibitor | C2708-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| A83-01 | ALK4/5/7 inhibitor | C2831-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| A769662 | AMPK activator | C2769-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CP-690550 (Tofacitinib) | JAK1/2/3 inhibitor | C2716-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CHIR99021 | GSK3-beta inhibitor | C2447-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| 7,8-Dihydroxyflavone | C7181-10 | 10 mg; 50 mg; 250 mg |
| LDN-193189 HCl | BMP type I receptors ALK2/3 inhibitor | C5364-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| NVP-LGK974 | Wnt inhibitor | C6545-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| RAD001 (Everolimus) | mTOR inhibitor | C7230-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GDC-0349 | mTOR inhibitor | C4034-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| BX-912 | PDK1 inhibitor | C2991-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| WYE125132 | mTOR inhibitor | C9125-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GDC-0980 (RG7422) | PI3K/mTOR inhibitor | C4098-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-XAV939 | Wnt/β-catenin Inhibitor | C9289-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| PS48 | PDK1 inhibitor | C7748-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RO4929097 | γ-secretase inhibitor | C7649-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Wnt-C59 | Wnt signaling inhibitor | C7641-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| BIBF1120 (Vargatef, Nintedanib) | VEGFR/PDGFR/FGFR inhibitor | C2311-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| YO-01027 (Dibenzazepine) | gamma-secretase inhibitor | C9601-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| XL147 | PI3K inhibitor | C9514-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Purmorphamine | Hedgehog signaling activator | C7976-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PP242 | mTOR inhibitor | C7724-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PKI-587 | PI3K/mTOR inhibitor | C7587-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PIK-93 | PI4K inhibitor | C7930-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Perifosine | Akt/PI3K inhibitor | C7374-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MK-2206 | Akt1/Akt2/Akt3 inhibitor | C6220-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2886721 | BACE inhibitor | C5288-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2109761 | TGF-β receptor type I/II inhibitor | C5210-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| KU-63794 | mTOR inhibitor | C5863-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ICG-001 | Wnt signaling inhibitor | C4001-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| IC-87114 | PI3Kδ inhibitor | C4287-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK2126458 | PI3K/mTOR inhibitor | C4212-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CUDC-907 | PI3K and HDAC inhibitor | C2907-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| AS-605240 | PI3K inhibitor | C2760-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SF1670 | PTEN inhibitor | C7316-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| 3-MA | C0362-10 | 10 mg; 50 mg; 250 mg |
| GDC-0068 | Pan-Akt inhibitor | C4006-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GDC-0449 (Vismodegib) | Hedgehog pathway inhibitor | C4044-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Rapamycin | mTOR inhibitor | C7272-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY294002 | PI3K inhibitor | C5929-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2157299 | TGF-β receptor inhibitor | C5921-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| LDN-193189 | BMP type I receptors ALK2/3 inhibitor | C5361-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| NVP-LDE225 | Smo inhibitor | C5332-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| 53AH | Wnt pathway inhibitor | C5324-2s | 2 mg; 10 mg; 50 mg |
| IWP-3 | Wnt inhibitor | C4971-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| ITDts | TGF-β pathway inhibitor | C4838-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| (+)-ITD-1 | TGF-β pathway inhibitor | C4832-1s | 1 mg;5 mg; 25 mg |
| (-)-ITD-1 | TGF-β pathway inhibitor | C4831-1s | 1 mg; 5 mg; 25 mg |
| ITD-1 | TGF-β pathway inhibitor | C4830-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Hh-Ag1.5 | Hedgehog pathway activator | C4412-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GDC-0941 (Pictilisib) | Class I PI3K kinase inhibitor | C4321-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Forskolin | Adenylate cyclase activator | C3677-10 | 10 mg; 50 mg; 250 mg |
| BMS-708163 (Avagacestat) | γ-secretase inhibitor | C2708-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| DAPT | γ-secretase inhibitor | C3178-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD8055 | mTOR inhibitor | C2955-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| A83-01 | ALK4/5/7 inhibitor | C2831-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| NVP-BKM120 | Pan-class I PI3K inhibitor | C2561-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-BGT226 | PI3K/mTOR inhibitor | C2482-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| NVP-BEZ235 | PI3K/mTOR inhibitor | C2392-10 | 10 mg; 50 mg; 250 mg |
| A-674563 | PKB/Akt inhibitor | C2167-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Cyclopamine | Hedgehog pathway inhibitor | C2925-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Talazoparib (BMN 673) | C2667-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Mocetinostat (MGCD0103) | C6623-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| EPZ-6438 | C3764-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Nutlin-3a | C6885-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LDN-57444 | UCH-L1inhibitor | C5574-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Trichostatin A (TSA) | HDAC inhibitor | C8742-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| AGI-5198 (IDH-C35) | IDH1 inhibitor | C2519-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CDDO (Bardoxolone) | anti-inflammatory | C2336-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| P22077 | USP7 inhibitor | C7220 | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| TMP195 | Class IIa HDAC inhibitor | C8619-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| TMP269 | Class IIa HDAC inhibitor | C8626-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| VX-765 | Caspase 1/Interleukin-converting enzyme inhibitor | C8976-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TMC125 (Etravirine) | HIV-1 reverse transcriptase inhibitor | C8125-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PSI-6206 (RO2433) | HCV RNA polymerase inhibitor | C7620-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Pirarubicin | DNA intercalator | C7461-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Ormetoprim | Dihydrofolate (DHF) reductase | C6763-10 | 10 mg; 50 mg; 250 mg |
| Lonidamine | Glycolysis inhibitor | C5664-10 | 10 mg; 50 mg; 250 mg |
| GW4064 | non-steroidal FXR agonist | C4940-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Docetaxel (Taxotere) | Microtubules binder/stabilizer | C3623-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Daunorubicin hydrochloride | DNA intercating agent | C3286-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AT7519 | CDK inhibitor | C2875-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ABT-263 (Navitoclax) | Bcl-2 family inhibitor | C2263-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Mitomycin C | DNA crosslinking agent | C6486-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SU5416 (Semaxinib) | Flk-1/KDR inhibitor | C7541-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PCI-34051 | HDAC8 inhibitor | C7340-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK1349572 (Dolutegravir) | HIV integrase inhibitor | C4134-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GSK126 | EZH2 inhibitor | C4126-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| BSI-201 (Iniparib) | PARP inhibitor | C2201-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| VX-680 (Tozasertib) | Aurora A inhibitor | C8916-10 | 10 mg; 50 mg; 250 mg |
| Vorinostat (SAHA) | Class I&II HDAC inhibitor | C8674-10 | 10 mg; 50 mg; 250 mg |
| Staurosporine | pan-kinase inhibitor | C7828-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| P7C3 | Neurogenic & neuroprotective agent | C7723-10 | 10 mg; 50 mg; 250 mg |
| BIBF1120 (Vargatef, Nintedanib) | VEGFR/PDGFR/FGFR inhibitor | C2311-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AG-014699 (PF-01367338, Rucaparib) | PARP1/2 inhibitor | C2401-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Temozolomide | DNA alkylating agent | C8366-10 | 10 mg; 50 mg; 250 mg |
| SP600125 | JNK2/JNK3 inhibitor | C7760-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PTC-124 (Ataluren) | Avoid early termination caused by nonsense mutation | C7124-10 | 10 mg; 50 mg; 250 mg |
| PS-341 (Bortezomib) | Proteasome inhibitor | C7734-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-3845 | FAAH inhibitor | C7384-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-AUY922 | HSP90 inhibitor | C6278-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MK-0518 (Raltegravir) | HIV-1 integrase inhibitor | C6051-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MG132 | Proteasome inhibitor | C6413-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2484595 (Evacetrapib) |CETP inhibitor | C5248-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| KU-55933 | ATM kinase inhibitor | C5855-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| JTT-705 (Dalcetrapib) | CETP inhibitor | C5705-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| INNO-406 (Bafetinib) | Abl/Lyn inhibitor | C4406-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK1210151A (I-BET 151) | BRD2/3/4 inhibitor | C4121-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| FG-4592 (ASP1517) | HIF prolyl-hydroxylase inhibitor | C3445-10 | 10 mg; 50 mg; 250 mg |
| CUDC-907 | PI3K and HDAC inhibitor | C2907-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Cisplatin | DNA crosslinker | C2488-10 | 10 mg; 50 mg; 250 mg |
| CI-1011 (Avasimibe) | ACAT inhibitor | C2410-10 | 10 mg; 50 mg; 250 mg |
| JNJ-28431754 (Canagliflozin) | SGLT2 inhibitor | C2262-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| BMS-512148 (Dapagliflozin) | SGLT2 inhibitor | C2512-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD5438 | CDK 1/2/9 inhibitor | C2543-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD2281 (Olaparib) | PARP1/2 inhibitor | C2228-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AS-1413 (Amonafide) | DNA intercalator | C2714-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Adriamycin (Doxorubicin) | DNA intercalator | C2374-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ACY-1215 (Rocilinostat) | HDAC6/8 inhibitor | C2121-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| ABT-888 (Veliparib) | PARP1/2 inhibitor | C2888-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Pyroxamide | HDAC inhibitor | C7376-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| S3I-201 (NSC74859) | Stat3 activity inhibitor | C7341-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| 3-MA | C0362-10 | 10 mg; 50 mg; 250 mg |
| CX-5461 | RNA Pol I inhibitor | C2954-2s | 2 mg; 10 mg; 50 mg |
| Necrostatin-1 | RIP1 inhibitor | C6221-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-LBH589 (Panobinostat) | HDAC inhibitor | C5245-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Spautin-1 | Autophagy inhibitor | C3430-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| AZD8055 | mTOR inhibitor | C2955-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIX-01294 | G9a HMTase inhibitor | C2491-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-BGT226 | PI3K/mTOR inhibitor | C2482-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| ABT-737 | Apoptosis inhibitor | C2281-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Abiraterone | P450 CYP17 inhibitor | C2247-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Reprime-5C (3000x) | Primary hepatocyte culture cocktail | K5266 | 0.5 ml |
| Talazoparib (BMN 673) | C2667-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Pemetrexed (LY-231514) | C5923-10 | 10 mg; 50 mg; 250 mg |
| Mocetinostat (MGCD0103) | C6623-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Fulvestrant (ICI-182780) | C4218-10 | 10 mg; 50 mg; 250 mg |
| Foretinib (GSK1363089) | C4136-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| EPZ-6438 | C3764-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Axitinib (AG 013736) | C2413-10 | 10 mg; 50 mg; 250 mg |
| VX-809 (Lumacaftor) | C8980-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY-2228820 | C5922-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BGJ398 (NVP-BGJ398) | C6245-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Nutlin-3a | C6885-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LDN-57444 | UCH-L1inhibitor | C5574-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| VX-770 (Ivacaftor) | CFTR potentiator | C8770-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BAY-73-4506 (Regorafenib) | Tyrosine kinase inhibitor | C2734-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-LGK974 | Wnt inhibitor | C6545-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Trichostatin A (TSA) | HDAC inhibitor | C8742-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| AGI-5198 (IDH-C35) | IDH1 inhibitor | C2519-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BI-1356 (Linagliptin) | DPP-IV/DPP-4 inhibitor | C2135-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AG-1024 | IGF-1R inhibitor | C2102-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CDDO (Bardoxolone) | anti-inflammatory | C2336-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| P22077 | USP7 inhibitor | C7220 | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| VX-765 | Caspase 1/Interleukin-converting enzyme inhibitor | C8976-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Tolrestat | Aldose reductase inhibitor | C8657-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TMC207 (Bedaquiline) | ATP synthase inhibitor | C8207 | 2 mg; 10 mg; 50 mg |
| TMC125 (Etravirine) | HIV-1 reverse transcriptase inhibitor | C8125-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| T-705 (Favipiravir) | Anti-influenza compound | C8705-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RAD001 (Everolimus) | mTOR inhibitor | C7230-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PSI-6206 (RO2433) | HCV RNA polymerase inhibitor | C7620-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| PQ401 | IGF-1R inhibitor | C7740-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PNU-282987 | nAChR agonist | C7282-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Pirarubicin | DNA intercalator | C7461-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Ormetoprim | Dihydrofolate (DHF) reductase | C6763-10 | 10 mg; 50 mg; 250 mg |
| Lonidamine | Glycolysis inhibitor | C5664-10 | 10 mg; 50 mg; 250 mg |
| Letrozole | Aromatase inhibitor | C5387-10 | 10 mg; 50 mg; 250 mg |
| Latanoprost | Prostaglandin F receptor (FP) agonist | C5282-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GW501516 | PPARδ agonist | C4950-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GW4064 | non-steroidal FXR agonist | C4940-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK1292263 | GPR119 agonist | C4129-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GF120918 (Elacridar) | P-glycoprotein (P-gp) inhibitor | C4312-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GDC-0349 | mTOR inhibitor | C4034-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Docetaxel (Taxotere) | Microtubules binder/stabilizer | C3623-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Daunorubicin hydrochloride | DNA intercating agent | C3286-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Cefdinir | Antibiotic | C2333-10 | 10 mg; 50 mg; 250 mg |
| AT7519 | CDK inhibitor | C2875-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AP26113 | ALK inhibitor | C2726-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Ambrisentan | Endothelin receptor type A/ETa antagonist | C2627-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ABT-263 (Navitoclax) | Bcl-2 family inhibitor | C2263-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AS-703026 (Pimasertib) | MEK1/2 inhibitor | C2770-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Mitomycin C | DNA crosslinking agent | C6486-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-AUY954 | S1P1 agonist | C6295-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Zanamivir | Neuraminidase inhibitor | C9262-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| YM155 | Survivin inhibitor | C9615-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| WYE125132 | mTOR inhibitor | C9125-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| SYN115 | Adenosine A(2a) receptor antagonist | C7911-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SU5416 (Semaxinib) | Flk-1/KDR inhibitor | C7541-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Prucalopride | 5-HT4 receptor agonist | C7782-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PCI-34051 | HDAC8 inhibitor | C7340-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ABT-378 (Lopinavir) | HIV-1 protease inhibitor | C2378-10 | 10 mg; 50 mg; 250 mg |
| GSK1349572 (Dolutegravir) | HIV integrase inhibitor | C4134-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GSK126 | EZH2 inhibitor | C4126-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GDC-0980 (RG7422) | PI3K/mTOR inhibitor | C4098-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| FK866 (APO866) | PBEF/NAMPT inhibitor | C3586-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TMC114 (Darunavir) | HIV-1 protease inhibitor | C8114-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CP-724714 | HER2 inhibitor | C2772-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BSI-201 (Iniparib) | PARP inhibitor | C2201-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Alcaftadine | Histamine (H1/H4) receptor antagonist | C2522-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-XAV939 | Wnt/β-catenin Inhibitor | C9289-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| VX-680 (Tozasertib) | Aurora A inhibitor | C8916-10 | 10 mg; 50 mg; 250 mg |
| Ursolic acid | C8776-10 | 10 mg; 50 mg; 250 mg |
| Vorinostat (SAHA) | Class I&II HDAC inhibitor | C8674-10 | 10 mg; 50 mg; 250 mg |
| SU5402 | FGFR/VEGFR/PDGFR inhibitor | C7854-1s | 1 mg;5 mg; 25 mg |
| Staurosporine | pan-kinase inhibitor | C7828-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| SRT1720 | SIRT inhibitor | C7781-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| P7C3 | Neurogenic & neuroprotective agent | C7723-10 | 10 mg; 50 mg; 250 mg |
| RO4929097 | γ-secretase inhibitor | C7649-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Wnt-C59 | Wnt signaling inhibitor | C7641-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Sitagliptin | DPP-IV/DPP-4 inhibitor | C7482-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| R406 | SYK inhibitor | C7406-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CP-358774 (Erlotinib, OSI-774) | EGFR inhibitor | C2735-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIBF1120 (Vargatef, Nintedanib) | VEGFR/PDGFR/FGFR inhibitor | C2311-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AG-014699 (PF-01367338, Rucaparib) | PARP1/2 inhibitor | C2401-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ZD6474 (Vandetanib) | KDR/VEGFR2 inhibitor | C9364-10 | 10 mg; 50 mg; 250 mg |
| ZD1839 (Gefitinib, Iressa) | EGFR inhibitor | C9318-10 | 10 mg; 50 mg; 250 mg |
| YO-01027 (Dibenzazepine) | gamma-secretase inhibitor | C9601-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| XL147 | PI3K inhibitor | C9514-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| VX-950 (Telaprevir) | HCV protease inhibitor | C8995-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| VX-702 | P38 MAPK inhibitor | C8970-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| VX-478 (Amprenavir) | HIV-1 protease inhibitor | C8947-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TG101348 (SAR302503) | JAK2 inhibitor | C8134-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| TG101209 | JAK2/3 inhibitor | C8120-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Temozolomide | DNA alkylating agent | C8366-10 | 10 mg; 50 mg; 250 mg |
| TAK-875 | GPR40 agonist | C8875-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Strontium ranelate | Promote osteoblast differentiation | C7876-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| STI571 (Imatinib, Gleevec) | Abl/cKit/PDGFR inhibitor | C6784-10 | 10 mg; 50 mg; 250 mg |
| SPM-927 (Lacosamide) | C7927-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SP600125 | JNK2/JNK3 inhibitor | C7760-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Sorafenib | Raf1 inhibitor | C7672-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SGX523 | cMET inhibitor | C7523-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SD-169 | p38 MAPK inhibitor | C7216-10 | 10 mg; 50 mg; 250 mg |
| SB203580 | p38 MAPK inhibitor | C7320-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RO318959 (Saquinavir) | HIV-1 protease inhibitor | C7318-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| R788 (Fostamatinib disodium) | Orally active Syk inhibitor | C7788-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PTC-124 (Ataluren) | Avoid early termination caused by nonsense mutation | C7124-10 | 10 mg; 50 mg; 250 mg |
| PS-341 (Bortezomib) | Proteasome inhibitor | C7734-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PP242 | mTOR inhibitor | C7724-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PLX-4720 | B-RAF inhibitor | C7420-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PLX-4032 (Vemurafenib) | B-Raf inhibitor | C7403-10 | 10 mg; 50 mg; 250 mg |
| PKI-587 | PI3K/mTOR inhibitor | C7587-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PIK-93 | PI4K inhibitor | C7930-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PHA-793887 | CDK2/5/7 inhibitor | C7793-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PHA-665752 | cMET/RON inhibitor | C7665-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-562271 | FAK/Pyk2 inhibitor | C7562-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-3845 | FAAH inhibitor | C7384-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-299804 (Dacomitinib) | HER1/2/3 inhibitor | C7299-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-2341066 (Crizotinib) | cMet/ALK inhibitor | C7234-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PF-04217903 | cMet inhibitor | C7042-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PD98059 | MEK inhibitor | C7980-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PD153035 | EGFR inhibitor | C7153-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PCI-32765 (Ibrutinib) | BTK inhibitor | C7327-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| OSI-906 (Linsitinib) | IFG-1R/IR inhibitor | C6906-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-TAE684 | ALK inhibitor | C6823-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-AUY922 | HSP90 inhibitor | C6278-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MK-2206 | Akt1/Akt2/Akt3 inhibitor | C6220-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MK-0518 (Raltegravir) | HIV-1 integrase inhibitor | C6051-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MG132 | Proteasome inhibitor | C6413-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MDV3100 (Enzalutamide) | AR antagonist | C6310-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY335979 (Zosuquidar) | P-glycoprotein modulator | C5335-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2886721 | BACE inhibitor | C5288-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2811376 | BACE inhibitor | C5281-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2784544 | JAK2 inhibitor | C5178-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2484595 (Evacetrapib) |CETP inhibitor | C5248-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| LY2109761 | TGF-β receptor type I/II inhibitor | C5210-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| LX7101 | LIMK2 inhibitor | C5971-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| KU-63794 | mTOR inhibitor | C5863-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| KU-55933 | ATM kinase inhibitor | C5855-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| JTT-705 (Dalcetrapib) | CETP inhibitor | C5705-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| INNO-406 (Bafetinib) | Abl/Lyn inhibitor | C4406-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ICG-001 | Wnt signaling inhibitor | C4001-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| IC-87114 | PI3Kδ inhibitor | C4287-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| HKI-272 (Neratinib) | HER2/EGFR inhibitor | C4272-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GW572016 (Lapatinib) | ErbB-2/EGFR inhibitor | C4920-10 | 10 mg; 50 mg; 250 mg |
| GSK2126458 | PI3K/mTOR inhibitor | C4212-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GSK1838705A | IGF-1R/IR/ALK inhibitor | C4183-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK1210151A (I-BET 151) | BRD2/3/4 inhibitor | C4121-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GSK1120212 (Trametinib) | MEK1/2 inhibitor | C4112-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GDC-0879 | B-Raf inhibitor | C4087-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| FG-4592 (ASP1517) | HIF prolyl-hydroxylase inhibitor | C3445-10 | 10 mg; 50 mg; 250 mg |
| Doripenem | Broad spectrum antibiotic | C3674-10 | 10 mg; 50 mg; 250 mg |
| Cyclophosphamide | DNA alkylating agent | C2936-10 | 10 mg; 50 mg; 250 mg |
| CX-4945 (Silmitasertib) | CK2a kinase inhibitor | C2949-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CUDC-907 | PI3K and HDAC inhibitor | C2907-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CP-868596 (Crenolanib) | PDGFR inhibitor | C2786-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Cisplatin | DNA crosslinker | C2488-10 | 10 mg; 50 mg; 250 mg |
| CI-1011 (Avasimibe) | ACAT inhibitor | C2410-10 | 10 mg; 50 mg; 250 mg |
| CGS-21680 | A2A receptor agonist | C2216-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| JNJ-28431754 (Canagliflozin) | SGLT2 inhibitor | C2262-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| BMS-777607 | Met/Axl/Ron inhibitor | C2777-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-599626 | Her1/Her2 inhibitor | C2599-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-512148 (Dapagliflozin) | SGLT2 inhibitor | C2512-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-477118 (Saxagliptin) | DPP-IV inhibitor | C2477-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-354825 (Dasatinib) | Abl/Src inhibitor | C2354-10 | 10 mg; 50 mg; 250 mg |
| BMS-232632 (Atazanavir) | HIV-1 protease inhibitor | C2232-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-207147 (Ravuconazole) | antifungal compound | C2207-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIBW2992 (Afatinib) | EGFR, Her2 inhibitor | C2929-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD6244 (Selumetinib) | MEK1 inhibitor | C2624-10 | 10 mg; 50 mg; 250 mg |
| AZD5438 | CDK 1/2/9 inhibitor | C2543-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD4547 | FGFR1/2/3 inhibitor | C2454-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD2281 (Olaparib) | PARP1/2 inhibitor | C2228-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZ-628 | Raf inhibitor | C2962-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AV-951 (Tivozanib) | VEGFR1/2/3, cKit, PDGFR inhibitor | C2895-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AS-605240 | PI3K inhibitor | C2760-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AS-1413 (Amonafide) | DNA intercalator | C2714-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AP24534 (Ponatinib) | Abl, Src, FGFR, VEGFR inhibitor | C2724-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AMG-706 (Motesanib) | Pan-VEGFR inhibitor | C2706-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AMD3100 (Plerixafor) | HIV-1 entry blocker | C2310-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Aliskiren | direct renin inhibitor | C2547-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AICAR | AMPK activator | C2422-10 | 10 mg; 50 mg; 250 mg |
| Adriamycin (Doxorubicin) | DNA intercalator | C2374-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ACY-1215 (Rocilinostat) | HDAC6/8 inhibitor | C2121-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| AC220 (Quizartinib) | FLT3 inhibitor | C2222-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| ABT-888 (Veliparib) | PARP1/2 inhibitor | C2888-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ABT-869 (Linifanib) | KDR, CSF-1R, FLT1/3, PDGFRb inhibitor | C2869-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Pyroxamide | HDAC inhibitor | C7376-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| S3I-201 (NSC74859) | Stat3 activity inhibitor | C7341-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| PD0332991 | Cdk4/6 inhibitor | C7306-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ABR-215062 (Laquinimod) | Immunomodulator | C2215-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GDC-0068 | Pan-Akt inhibitor | C4006-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| CX-5461 | RNA Pol I inhibitor | C2954-2s | 2 mg; 10 mg; 50 mg |
| XL184 (Cabozanitinib) | VEGFR2/MET inhibitor | C9518-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GDC-0449 (Vismodegib) | Hedgehog pathway inhibitor | C4044-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Rapamycin | mTOR inhibitor | C7272-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| MLN-8237 | Autota A kinase inhibitor | C6561-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Leukadherin-1 | Integrin CD11b/CD18 agonist | C5385-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| NVP-LBH589 (Panobinostat) | HDAC inhibitor | C5245-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| J147 | Neuroprotective compound | C5147-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| INCB018424 | JAK1/2 inhibitor | C4622-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| GDC-0941 (Pictilisib) | Class I PI3K kinase inhibitor | C4321-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| FTY720 | S1P receptor 1/3/4/5 agonist | C3897-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BMS-708163 (Avagacestat) | γ-secretase inhibitor | C2708-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| AZD8055 | mTOR inhibitor | C2955-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| A769662 | AMPK activator | C2769-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CP-690550 (Tofacitinib) | JAK1/2/3 inhibitor | C2716-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| NVP-BKM120 | Pan-class I PI3K inhibitor | C2561-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIX-01294 | G9a HMTase inhibitor | C2491-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-BGT226 | PI3K/mTOR inhibitor | C2482-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| BIIB021 (CNF2024) | HSP90 inhibitor | C2442-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| NVP-BEZ235 | PI3K/mTOR inhibitor | C2392-10 | 10 mg; 50 mg; 250 mg |
| A-674563 | PKB/Akt inhibitor | C2167-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Cyclopamine | Hedgehog pathway inhibitor | C2925-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| ABT-737 | Apoptosis inhibitor | C2281-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Abiraterone | P450 CYP17 inhibitor | C2247-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| 7,8-Dihydroxyflavone | C7181-10 | 10 mg; 50 mg; 250 mg |
| LDN-193189 HCl | BMP type I receptors ALK2/3 inhibitor | C5364-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Reprime-5C (3000x) | Primary hepatocyte culture cocktail | K5266 | 0.5 ml |
| NVP-LGK974 | Wnt inhibitor | C6545-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Trichostatin A (TSA) | HDAC inhibitor | C8742-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Repro-miRNA | K6471 | - |
| Repro-PACT | K7228-500 | 0.5mL of 1000x; 0.2mL of 5000x; 1.0mL of 5000x |
| Repro-ThiPSC | Enhance reprogramming efficiency cocktail | K8447-500 | 0.5mL of 1000x |
| Repro-nSC (1000x) | K6720-500 | 0.5mL of 1000x |
| Repro-nLS3i (1000x) | K6572-500 | 0.5mL of 1000x |
| Repro-n3i (1000x) | Neuron differentiation cocktail | K6571-500 | 0.5mL of 1000x |
| Repro-nLS (1000x) | neural/neuronal cell generation cocktail | K6570-500 | 0.5mL of 1000x |
| Repro-nLSC (1000x) | neural/neuronal cell generation cocktail | K5722-500 | 0.5mL of 1000x |
| Repro-ACTH2i (1000x) | K2284 | 0.25mL of 1000x |
| NVP-XAV939 | Wnt/β-catenin Inhibitor | C9289-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Y-27632 | ROCK inhibitor | C9127-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Thiazovivin | ROCK inhibitor | C8442-1s | 1 mg;5 mg; 25 mg |
| Pyrintegrin | C7974-1s | 1 mg;5 mg; 25 mg |
| SU5402 | FGFR/VEGFR/PDGFR inhibitor | C7854-1s | 1 mg;5 mg; 25 mg |
| PS48 | PDK1 inhibitor | C7748-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RO4929097 | γ-secretase inhibitor | C7649-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Wnt-C59 | Wnt signaling inhibitor | C7641-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Strontium ranelate | Promote osteoblast differentiation | C7876-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| RU58841 | nonsteroidal anti-androgen | C7858-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Purmorphamine | Hedgehog signaling activator | C7976-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| ICG-001 | Wnt signaling inhibitor | C4001-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| Reversine | A3 adenosine receptor antagonist | C7383-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Pyroxamide | HDAC inhibitor | C7376-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| GDC-0449 (Vismodegib) | Hedgehog pathway inhibitor | C4044-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| SB431542 | TGF-β type I (ALK4/5/7) inhibitor | C7243-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LY2157299 | TGF-β receptor inhibitor | C5921-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| KHS101 | C5471-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| LDN-193189 | BMP type I receptors ALK2/3 inhibitor | C5361-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| NVP-LDE225 | Smo inhibitor | C5332-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| 53AH | Wnt pathway inhibitor | C5324-2s | 2 mg; 10 mg; 50 mg |
| Kartogenin | Chondrocyte differentiation | C5278-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| IWP-3 | Wnt inhibitor | C4971-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| ITDts | TGF-β pathway inhibitor | C4838-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| (+)-ITD-1 | TGF-β pathway inhibitor | C4832-1s | 1 mg;5 mg; 25 mg |
| (-)-ITD-1 | TGF-β pathway inhibitor | C4831-1s | 1 mg; 5 mg; 25 mg |
| ITD-1 | TGF-β pathway inhibitor | C4830-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Forskolin | Adenylate cyclase activator | C3677-10 | 10 mg; 50 mg; 250 mg |
| Spautin-1 | Autophagy inhibitor | C3430-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| DAPT | γ-secretase inhibitor | C3178-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| A83-01 | ALK4/5/7 inhibitor | C2831-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| A769662 | AMPK activator | C2769-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| BIX-01294 | G9a HMTase inhibitor | C2491-5 | 5 mg (10 mM solution in DMSO); 5 mg (powder); 25 mg (powder); 100 mg (powder) |
| CHIR99021 | GSK3-beta inhibitor | C2447-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| Cyclopamine | Hedgehog pathway inhibitor | C2925-2s | 2 mg (10 mM solution in DMSO); 2 mg (powder); 10 mg (powder); 50 mg (powder) |
| StemRegenin 1 (SR1) | Promote CD34+ cell expansion | C7710-1s | 1 mg;5 mg; 25 mg |
